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ABSTRACT 
Objective: The objective of this study was to evaluate the in vitro and in vivo anti-inflammatory properties of the aqueous extract and fractions of 
the trunk bark of Acacia nilotica. 
Methods: A maceration of the powder of the trunks barks of the plant was realized. Then the aqueous macerate obtained was fractionated with 
dichloromethane, butanol and ethyl acetate successively. The phenolic compounds of the aqueous extract, butanol and ethyl acetate fractions were 
identified by HPLC/DAD. Lipoxygenase and phospholipase inhibition tests with the aqueous extract and the butanol and ethyl acetate fractions were 
carried out. The anti-inflammatory potential of the aqueous extract was assessed in vivo by the anti-edema test with carrageenan and the analgesic test 
with acetic acid at different doses (200 mg/ml; 400 mg/ml; 600 mg/ml). Aspirin (200 mg/ml) and paracetamol (200 mg/ml) were used as a reference. 
Results: The HPLC/DAD analysis of the extracts revealed that gallic acid is the most abundant phenol acid in the extracts. The aqueous extract 
inhibited lipoxygenase (IC50 = 18.32±1.18 μg/ml), phospholipase (11.44±0.32% per 100 μg/ml) and cyclooxygenase (56.48±0.29% for 100 μg/ml) 
as well as its tested fractions. It also reduced edema and pain in the mice by more than 50% from the 400 mg/ml dose.  
Conclusion: Aqueous extract of Acacia nilotica has anti-inflammatory properties. Hence its use in traditional medicine in the treatment of 
inflammation. 
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INTRODUCTION 
Inflammation is a common reaction of the body to restore 
homeostasis that would be disrupted by infection, contaminant or 
trauma [1]. This inflammatory reaction leads to a leakage of the 
plasma proteins from the vascular system through tissue injury or 
evolves into chronic inflammation.  
The resolution of the inflammatory process helps protect the tissues 
from been damage and prevent them to progress to chronic 
inflammation. There are steroidal anti-inflammatory drugs (AIS) and 
nonsteroidal anti-inflammatory drugs (NSAIDs) that are used to 
treat inflammation. They block the inflammatory process by 
cyclooxygenase inhibition. It is the most used therapeutic class and 
often without any prescription [2], which leads to harmful 
consequences. This excessive use of NSAIDs or AIS causes ulcers [3], 
kidney disorders [4], cardiovascular disorders, etc. 
The search for a new anti-inflammatory molecule with other 
pathways of action is necessary to reduce or even eliminate the 
undesirable effects during the treatments. 
Medicinal plants remain the richest and most diverse source for the 
discovery of new active molecules. 
This is the example of tramadol painkiller found in 2013, which had 
a very interesting content in the roots of the plant Sarcocephalus 
latifolius, however, synthesized since the 1970s. 
In Burkina faso, rural populations use these medicinal plants to treat 
inflammation with fewer side effects [5]. 
The anti-inflammatory efficacy of some of these plants, such as 
Pterocarpus erinaceus Poir. (Fabaceae)[6] and Saba senegalensis (A. 
DC) Pichon (Apocynaceae) [7] has been demonstrated. Flavonoids 
such as quercetin [8] or tannins such as epicatechin [9] would confer 
on to these plants their anti-inflammatory properties. Acacia nilotica 
var. adansonii is one of those plants used by traditional healers to 
treat inflammation and gastritis [10]. 
It is in this context that the present study takes place to evaluate the 
anti-inflammatory efficacy of Acacia nilotica var adansonii. Its 
anthelminthic properties [11] and antibacterial [12] have already 
been proven. The objective of this study was to assess the anti-
inflammatory properties of the aqueous macerate of Acacia nilotica 
var adansonii trunk bark from enzymatic test, anti-edema and 
analgesic in vivo after HPLC/DAD analysis. 
MATERIALS AND METHODS 
Plants  
The Acacia nilotica var adansonii plant was harvested 140km from 
Ouagadougou in the Central-East region [13]. It was identified under 
number HNBU00210 at the herbarium of the National Center for 
Scientific and Technological Research (CNRST). The study extract 
was prepared according to the ethnopharmacological indication.  
Extraction and fraction  
The aqueous maceration was an extract model adopted for 
evaluation. A test sample of 200 g of plant material (bark powder) 
was macerated for 24 h. The macerate obtained was concentrated in 
an oven and then fractionated by the liquid/liquid method. 
Fractionation of the aqueous extract was carried out using, 
successively, the solvents dichloromethane, ethyl acetate and 
butanol. The different fractions obtained were condensed in a 
rotavapor and then oven-dried. 
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Substances and pharmacological reagents 
The following reference products were required for the various 
tests. Carrageenan, acetic acid, acetylsalicylic acid, paracetamol were 
obtained from Sigma-Aldrich. Linoleic acid, lipoxygenase, 
cyclooxygenase, DTNB, Buffer, Diheptanoythiol-PC, phospholipase 
(sPLA2) were derived from Cayman. 
Identification of phenolic compounds of aqueous extract, ethyl 
acetate and butanol fraction of Acacia niloticavar adansonii by 
HPLC/DAD 
The analysis of the phenolic compounds was by HPLC/DAD 
according to the method Castellari et al. [14]. It is a model 1100 
HPLC system equipped with a photodiode array detector (Agilent 
Technologies, Palo Alto, California, USA) with Chemstation software 
(Hewlett-Packard, Waldbronn, Germany). For these, 13 phenolic 
compounds (Sigma-Aldrich, Milan, Italy) that are gallic acid; 
protocatechuic acid; p-hydroxybenzoic acid; gentisic acid; m-benzoic 
acid; vanillic acid; Catechin syringic acid; epicatechin; ferulic acid; 
sinapinic acid; trihydrate; rutin; quercetin were used as standards. 
Standard solutions were prepared with an ethanol-water solvent 
(75: 25 v/v) HPLC grade for a concentration of 5 μg/ml. Extracts and 
standards were filtered with the 0.22 μm filter glass. After filtration, 
the solutions were directly injected into the HPLC/DAD system. The 
elution solvents HPLC grade were methanol-distilled water (2.5: 
97.5, v/v) with H3PO4 at pH3 and methanol-distilled water (50:50 
v/v) with H3PO4 at pH 3. The separations were performed on a 100 
mm x 4.6 mm (Merck) RP-C18 monolithic column at a temperature of 
30 ° C±1 using a C-150 furnace (Eldex Laboratories, Napa, CA, USA). 
The injection volume was 10 μl. The elution rate was 2.1 ml/min for 
36 min with a multistage gradient (table 1). The identification of the 
compounds of each sample, was made by comparing the retention 
times and spectra (200-450 nm) of their peak chromatograms with 
those of the standard compounds. Quantification was performed 
using a standard curve obtained by injecting known amounts of pure 
compounds as external standards. 
  
Table 1: HPLC solvents A and B gradient elution in relation to time 
Time (min)  A%  B%  Elution 
0 100 0 Isocratic 
10 100 0 Isocratic 
15 82 18 Linear gradient  
20 75 25 Linear gradient  
22 65 35 Linear gradient  
30 0 100 Linear gradient  
34 0 100 Isocratic 
35 100 0 linear gradient 
36 100 0 Isocratic 
-A: Methanol-water-distilled (2.5:97.5, v/v) à pH 3 avec H3PO4;-B: Methanol-water-distilled (50:50, v/v) à pH 3 avec H3PO4 
 
Inhibition of lipoxygenase (LOX) 
It was carried out according to the method described by Malterud et 
al., [15]. On a 96-well microplate, the following reaction mixtures 
were made. Enzyme control mixture consisting of 153.75 μl of 
borate buffer plus and 146.25 μl of LOX solution (400 U/ml). The 
mixture of enzyme activity composition was 3.75 μl of the borate 
buffer plus 146.25 μl of the LOX solution and 150 μl of linoleic acid 
solution (1.25 mmol). The control of the extract mixture 
composition was 146.25 μl of the LOX solution, 3.75 μl of the extract 
and 150 μl borate buffer. The mixture of extract activity consisting of 
146.25 μl of the LOX solution, 3.75 μl of extract and 150 μl of linoleic 
acid solution (substrate). 
Each reaction mixture is made in triplecata with the extract at 
different concentrations (100; 50; 25; 12.5; 6.25; 3.175 μg. ml) in the 
wells of the microplate. The follow-up of the variation of the reaction 
mixture is done by photospectrometry (Agilent 8453) at a 
wavelength of 234 nm, just after the addition of linoleic acid. 
The percentage inhibition of lipoxygenase by the extracts is 
calculated by the following formula:  
I (%) =  100 ×  [(DO. enzyme − DO. echantillon) DO. enzyme]⁄  
DOenzyme= DOEn. actif–DOEn. blanc; DOechantillon= DOactif Ech–DOblanc Ech 
The IC50 is determined from a parabolic plot of concentration as a 
function of the percent inhibition calculated I (%). 
Inhibition of phospholipase A2 (sPLA2) 
Test was realized according to the manufacture’s instruction 
(Caymans COX Colorimetric, 760111)[16]. In a first well of the 
multiwell plate (enzyme test), 10 μl of methanol (HPLC) plus 10 μl 
sPLA 2 and 200 μl of Diheptanoythiol-PC substrate are mixed there. 
In the second well, 10 µlsPLA2 plus 10 µl of extract (8 mg/ml) and 
200 µl of Diheptanoythiol-PC substrate are added thereto. In the 
third well, it is a mixture of 10 μl of methanol (HPLC) with 10 μl of 
buffer and 200 μl of Diheptanoythiol-PC substrate. Each mixture is 
made in triplicate then the entire device is allowed to incubate for 
15 min at 25 °C. At the end of the 15 min, a mixing of the plate is 
carried out for 1 min after the addition of 10 μl of DTNB in each well. 
After mixing, the reaction mixture is followed by photospectrometry 
(Agilent 8453) at a wavelength of 405 nm. 
The percentage inhibition of sPLA2 is calculated by the following 
formula:  
I (%) =  100 ×  [(AEA − AIA) AEA]⁄  
AEA: Activity enzyme test absorbance; Enzyme test activity: (Enz 
Test abs–blank abs); 
AIA: Activity inhibition test absorbance; Activity Inhibition Test: 
(Abs Inh Test-blank abs) 
Inhibition of cyclooxygenase (COX-1 and COX-2) 
The cyclooxygenase inhibition test was evaluated according to the 
manufacture’s instruction (Caymans COX Colorimetric, 760111)[16]. 
A reaction mixture of 10 μl of an extract with 10 μl of the prepared 
enzyme, 10 μl of hemin and 150 μl of diluted Buffer buffer is 
prepared in a well of microplate 96-wells. The same mixture is made 
without the extract in another well but supplemented with 10 μl of 
the extract dilution solvent. A blank consisting of 160 μl buffer 
diluted, 10 μl of hermine and 10 μl of the dilution solvent of the 
extract is also realized. The whole device is stirred and left in 
incubation for 5 min. Then 20 μl of arachidonic acid (Substrate) and 
a colorimetric substrate is added to all wells. The plate is shaken a 
second time and incubated for 2 min before reading at the 590 nm 
photo spectrometer (Agilent 8453). The reaction mixtures were in 
triplicate with indomethacin and salicylic acetic acid as reference. 
The formula below makes it possible to determine the percentage 
inhibition of cyclooxygenase by the extract. 
I (%) =  100 ×  [(AEA − AIA) AEA]⁄  
AEA: Activity enzyme test absorbance; Enzyme test activity: (Enz 
Test abs–blank abs); 
AIA: Activity inhibition test absorbance; Activity Inhibition Test: 
(Abs Inh Test-blank abs). 
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Anti-edematous to the carrageenan testing 
This method based on measuring the volume of the mice paw before 
and after induction of inflammation (edema) to carrageenan [18].  
Each group of mice received a dose of the extract (200 mg, 400 mg, 
and 600 mg), acetylsalicylic acid (200 mg) and water (blank), 
which was administered per os. After 1h of administration, the 
initial volume of the right hind paw of the mice is measured. Then 
in the metatarsal region of this paw, edema was achieved by 
injection of 0.05 ml of carrageenan (1% suspended in NaCl 0.9%). 
After 1h of induction of edema, the volume of the paw is measured. 
Then at 3 and 5 o'clock. From three measurements (difference of 
less than 4%), the average volume of edema of the paw is 
calculated. 
The percent inhibition of paw edema of the treated mice paws was 
determined compared to that of the blank control mice. It’s 
determined according to the formula:  
I (%) =  100 ×  [(A − B) A]⁄  
A: represents the average difference in the volume of increase of the 
paw of the mice of the blank control group;  
B: represents the average difference in the volume of increase in the 
paw of the mice treated. 
The percentage of inhibition of the extract compared with that of 
acetylsalicylic acid (reference) makes it possible to assess the anti-
inflammatory effect of the extract. 
Analgesic activities (Acetic acid test) 
The study of the analgesic activity was carried out according to the 
method described by Sawadogo et al., [19].  
Mice were fasted for 17 h. Each groups of mice received a 
corresponding oral dose of the extract (200 mg, 400 mg, 600 mg). 
One control group received distilled water (blank) and another 
batch the reference compound paracetamol at a dose of 200 mg. 
After 1h of administration of the substances, an injection with acetic 
acid intraperitoneally on the mice was carried out at a dose of 10 
ml/kg. The injection of acetic acid (0.6%) causes acute pain in the 
mice which is manifested by stretching of the hind legs and 
contortion of the dorso-abdominal muscles. The contortions of each 
mouse were counted 5 min after injection for 15 min. The analgesic 
effect was evaluated according to the following formula:  
I (%) =  100 ×  [(Wb − Wt) Wb]⁄  
Wb: an average of the number of contortions of mice in the blank 
control group; Wt: an average of the number of contortion of the 
mice in the batch. 
Analysis of results 
Calculations of percentages of inhibitions performed with the MS 
Excel software. The results of the pharmacological study expressed 
as average±Standard Mean Error (E. S. M.). The different fig. were 
plotted using GraphPad Software Prism version 5.01. The series 
considered significant when the probability of error (p) is lower 
than the agreed risk: 0.05 (p<0.05). 
 
 
Fig. 1: Chromatogram of extracts at 280 nm, ---DAD1 B: Fraction butanolic; ----DAD1 B: Fraction acetate d’ethyl; ----DAD1 B: Extract aqueous 
 
 
Fig. 2: Chromatogram of extracts at 256 nm, ---DAD1 B: Fraction butanolic; ----DAD1 B: Fraction acetate d’ethyl; ----DAD1 B: Extract 
aqueous 
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RESULTS 
Identification of phenolic compounds of aqueous extract, ethyl acetate 
and butanol fraction of Acacia nilotica var adansonii by HPLC/DAD 
Analysis of aqueous extract, ethyl acetate and butanol fraction by HPLC 
revealed the presence of a certain number of phenolic acids indicated in 
table 2 and fig. (1; 2; 3; 4). Gallic acid had the highest content in the 
aqueous extract (843.56 μg, g-1), in the ethyl acetate fraction (1500.20 
μg. g-1) and in the butanol fraction (365.18 μg. g-1). Only ethyl acetate 
fraction revealed high m-hydroxybenzoic acid content (996.18 μg. g-1). It 
is in this fraction the quercetin was identified.  
This Chromatogram show the molecule which were identified at 280 
nm; (1) Gallic acid; (5) m-hydroxybenzoic acid; (7) Catechin; (8) 
Syringic acid; (9) epi-catechin. 
The pics of this chromatogram, which were identified, are: (2) 
protocatechic acid; (3) p-hydroxybenzoic acid; (6) vanillic acid. 
The molecules, which were, identify at 324 nm; (4) gentisicacid; (10) 
acid ferulic; 
The molecules pics which identified on this spectrum at were 365 
nm: (11) acid Sinapinic; (12) trihydrate rutin; (13) Quercetin. 
  
 




Fig. 4: Chromatogram of extracts at 365 nm, ---DAD1 B: Fraction butanolic; ----DAD1 B: Fraction acetate d’ethyl; ----DAD1 B: Extract 
aqueous 
 
Table 2: Retention time, wavelength and mass characteristic of phenolic compounds detected 
S. No. Compounds tr (min) λ (nm) Extract aqueous 
(µg. g-1) 
Fraction  acetate ethyl 
(µg. g-1) 
Fraction butanol (µg. g-1) 
1 Gallic acid 4,3 280 843,56 1500,20 365,18 
2  Protocatechic acid 7,2 256 0,46 0,93 0,40 
3  p-hydroxybenzoic acid 9,7 256 0,80 1,65 0,31 
4 gentisicacid 11,3 324 9,95 2,42 3,26 
5 m-hydroxybenzoicacid 12,7 280 2,17 996,18 20,60 
6 vanillic acid 12,6 256 9,30 25,99 0,67 
7 Catechin 15,9 280 4,41 18,51 4,56 
8 syringicacid 16,6 280 4,02 12,07 3,14 
9 epi-catechin 17,8 280 2,99 7,92 1,55 
10 acid ferulic 21,2 324  0,04  
11 acid Sinapinic 22,6 324 3,74   
12 trihydrate rutin  24,9 365 1,39 5,60  
13 Quercetin 36,8 365  0,59  
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Enzyme inhibition: lipoxygenase, phospholipase and 
cyclooxygenases 
The aqueous extract and its two fractions showed a percentage 
inhibition of COX-2 cyclooxygenase greater than 50% (table 3). But 
on cyclooxygenase COX-1, the percentage inhibition was less than 
50% for the aqueous extract and the butanol fraction. Only the 
fraction of ethyl acetate had a percentage higher than 50% 
(52.04±0.99) against COX-1. 
The highest percentage inhibition (88.46±0.21) of the phospholipase 
was also obtained with the ethyl acetate fraction at 100 µg/ml. 
Nevertheless, its aqueous extract showed the best inhibition (IC50 = 
18.32±1.18 μg/ml) of lipoxygenase. 
 
Table 3: Enzyme inhibition (lipoxygenase, phospholipase and cyclooxygenases) of A. nilotica bark extract 
Extract (n=3) FB FAE AE AAS 
%Inh COX-2 (at 100 µg/ml) 55.07±0.69 59.19±1.43 56.48±0.29 16.58±1.45 
%Inh COX-1 (at 100 µg/ml) 45.34±0.35 52.04±0.99 36.05±2.89 0 
%Inh sPLA2 (at 100 µg/ml) 61.50±0.13 88.46±0.21 11.44±0.33 21±0.1 
LOX (IC50µg/ml) 31.30±0.14 23.91±2.64 18.33±1.9 - 
The values are expressed on average±SEM. EA: aqueous extract; FAE: ethyl acetate fraction; FB: butanol fraction; AAS: acetylsalicylic acid 
 
Anti-edematous to the carrageenan testing 
The results of the test of inhibition of edema of mice paw by the 
aqueous Acacia nilotica extract are shown in the table 4. These 
results show an inhibitory effect concentration dependent on the 
extract and function of time (fig. 5). The strong inhibition of edema 
was obtained at 600 mg/ml (68.73%±0.01) at 5th h. 
Analgesic activities 
The mice contortion inhibition test by the aqueous Acacia nilotica 
extract revealed the results summarized in the table 5. The analgesic 
effect of the extract is dependent on concentration. The dose of 600 
mg (42.76%) indicated the strongest inhibition close to that of 
paracetamol at 200 mg (63.82%). 
 
 
Fig. 5: Variation of edema volume of mice paw at 1h, 3h and 5h, The values are expressed on average±SEM, *p<0.05; **p<0.01; ***p<0.001 
is considered significant compared to the control (Water) 
 
Table 4: The percentage inhibition of the volume of the paw at different concentrations of the aqueous extract after 1 h; 3h; 5h of time 
after injection of carrageen an 
Extract (n=6) AAS 200 mg EA 200 mg EA 400 mg EA 600 mg 
Temps % in h % in h % in h % in h 
1H 27.62±0.02 17.89±0.01 28.57±0.04 35.24±0.02 
3H 48.66±0.02 29.71±0.02 47.98±0.03 64.43±0.02 
5H 84.73±0.01 49.69±0.01 60.48±0.56 68.73±0.01 
The values are expressed on average±SEM. EA: aqueous extract; AAS: acetylsalicylic acid 
 
Table 5: Percent inhibition of contortions at different concentrations of the extract 
eExtract (n=6) Water EA 200 mg EA 400 mg EA 600 mg Para 200 mg 
Contortion number 50.67±1.15 34.33±1.53* 31±2* 29±1.73* 18.33±0.58** 
%Inhibition 0 32.24 38.81 42.76 63.82 
The values are expressed on average±SEM, *p<0.05; **p<0.01 is considered significant compared to the control. EA: aqueous extract; Para: 
Paracetamol 
Boly et al. 
Int J Pharm Pharm Sci, Vol 13, Issue 1, 40-46 
45 
DISCUSSION  
HPLC analysis made possible to identify 13 phenols molecules in the 
aqueous extract of Acacia nilotica and in its two fractions. Of these 
polyphenols identified, gallic acid had the highest content in the 
aqueous extract (843.56 μg, g-1), in the ethyl acetate fraction 
(1500.20 μg. g-1) and in the butanolic fraction (365.18 μg. g-1). 
Gallic acid content of aqueous extract is better than gallic acid 
content (544 μg. g-1) in ethanolic extract of Acacia nilotica var 
nilotica [20]. The catechin, quercetin and rutin, which identified in 
aqueous extract, were also reveal in the ethanol extract of Acacia 
nilotica var nilotica [20]. Singh et al., revealed the presence of ferric 
acid, hydroxybenzoic acid and epicatechin in the methanolic extract 
of pod of Acacia nilotica var nilotica by mass spectrometry (MS/MS) 
[21]. These molecules were also identified in the aqueous extract of 
barks Acacia nilotica var adansonii.  
The reduced number of standards did not allow the identification of 
other phytochemicals, whose peaks of high intensity appeared on 
the chromatograms. For example, at the length of 365 nm and the 
retention time of fewer than 5 min, two unidentified major peaks 
were observed on the chromatogram of the aqueous extract. 
The anti-edema, analgesic, inhibition of lipoxygenase, phospholipase 
and cyclooxygenase tests allowed to appreciate anti-inflammatory 
properties of the extracts. 
Indeed, the aqueous extract and its fractions strongly inhibited the 
activity of lipoxygenase. The best inhibition was obtained with the 
aqueous extract (IC50 = 18.32±1.18 μg/ml) followed butanol fraction 
and ethyl acetate. This shows a decrease of the inhibitory potential of 
the aqueous extract by the fractionation effect. The inhibitory action of 
LOX would be by synergistic action of molecules groups such as the 
catechinand epicatechin that make up the aqueous extract. It was 
demonstrated epicatechin inhibiting 5-lipoxygenase-1 [22] and 
catechin inhibiting mackerel muscle LOX [23]. The absence of one or 
more molecules in the extract would reduce this inhibitory power. The 
inhibitory effect of the aqueous extract of LOX is better than that of V. 
colorata (42.76±2.45% at 100 μg/ml) [24]. 
On the other hand, on the phospholipase, the inhibitory action of the 
aqueous extract was weak compared to those of the fractions. The 
ethyl acetate fraction showed the highest percent inhibition 
(88.46±0.21%) followed by the butanol fraction and the aqueous 
extract. This percentage inhibition was higher than that of aspirin 
(21±0.1% to 100 μg/ml). Tannins would be responsible for this 
phospholipase inhibitory activity. This was showed with gallic acid 
and hydroxybenzoïc acid, which inhibited phospholipase activity 
[25]. Moreover, there is a strong correlation between the tannin 
content and the inhibitory activity of phospholipase [26]. 
Aqueous extract and its fractions showed a strong inhibitory effect 
on COX-2 less than on COX1. This inhibitory power of the extracts 
was better compared to that of aspirin, which had no effect on COX-
1. The results obtained by Elgorashi et al., [27] was indicated an 
inhibitory effect equal to 44.1±3.4% on COX-2 and 50.9±2.4% on 
COX-1 by the methanol extract of bark of Acacia nilotica var 
tomentosa at 250 μg/ml. This shows a better efficiency of the 
aqueous extract of the Acacia nilotica var adansonii on COX-2 
(56.48±0.29%) and COX-1 (36.05±2.89%) at 100 μg/ml. 
Indomethacin, however, remains better on COX-1 (95.0±48%) 
compared to the aqueous extract and its fractions [28]. Flavonoids 
and tannins would be responsible for this cyclooxygenase inhibiting 
capacity by extracts. Some of their molecules, flavonols and flavones, 
have been identified as cyclooxygenases inhibitors [29]. The affinity 
of extracts for COX-2 may be related to the presence of apigenin and 
catechin, which are COX-2 inhibitors [30]. 
The results of the anti-edema test shows that the aqueous extract is 
endowed with anti-edema property. It inhibited edema development 
by more than 50% compared to white at 400 mg/kg (60.48±0.56) at 
the 5th hour and at 600 mg/kg (64.43±0.02) from the 3rd hour. The 
effect of the extract is more significant from the second phase of 
inflammation. Leukotrienes and prostaglandins would continue the 
inflammatory process after the first few hours [31]. This means that 
the extract would have acted by blocking the production of 
leukotrienes or prostaglandins by inhibition of lipoxygenase or 
cyclooxygenase. The percentage value of inhibition of lipoxygenase 
(IC50 = 18.32 μg/ml) and cyclooxygenase (56.48±0.29% for 
100μg/ml) could corroborate this mechanism of action of the extract 
in vivo. The effect of aspirin, however, remains greater with more 
than 80% inhibition of the development of edema (84.73±0.01). The 
methanolic extract of the fruit of the Acacia nilotica var nilotica has 
also a significantly higher effect (68.86%) than of the aqueous 
extract at a dose of 300 mg/kg [32]. However, the effect at a dose of 
600 mg is greater than of aspirin at the dose of 200 mg/kg at the 1st 
and 3rd hour (table 1). This could also reflect an inhibition of 
histamine and serotonin to a lesser extent, or even phospholipase by 
the extract. This weak action on phospholipase is confirmed by in 
vitro inhibition of 11.44% at 100 μg/ml of aqueous extract. 
The analgesic effect of the aqueous extract was significant, nearly 40% 
reduction in pain sensation at 400 mg/kg (38.81 %) dose. It is a 
concentration-dependent effect. But less high than of paracetamol (63.82 
%) and of Metamizole [33]. The effect of the 400 mg/kg dose of the 
aqueous extract of the bark is not significantly different than of the 
methanolic fruit extract (41.31%) at of 300 mg/kg dose [34]. The effect 
is also less than of plant Solanum Surattense [35]. The pain caused by 
acetic acid is indirect by release of prostaglandin-leukotrienes in the 
peritoneum that induce the stimulation of nociceptive neurons. The 
extract could therefore have inhibited the pain by preventing the 
production of prostaglandin-leukotrienes, with regard to its 
cyclooxygenase, lipoxygenase and phospholipase inhibiting properties. 
This anti-inflammatory property of the aqueous extract is due to the 
phytochemical groups that it contains including flavonoids and 
tannins. These phytochemical groups and many others are 
recognized to have very valuable anti-inflammatory properties [36]. 
CONCLUSION  
The aqueous extract of Acacia nilotica has demonstrated an anti-
edematous and analgesic effect very significant in terms of the 
results obtained. It is therefore endowed with anti-inflammatory 
property. It would acts by inhibition of lipoxygenase, phospholipase 
and cyclooxygenase to a lesser extent. Its use by traditional healers 
to treat inflammation and gastritis is justified. 
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